Results 261 to 270 of about 95,251 (337)

Immune-checkpoint targeting drug conjugates: a novel class of promising therapeutic agents for cancer treatment. [PDF]

open access: yesNPJ Precis Oncol
Marchesi S   +5 more
europepmc   +1 more source

Feeding Profit: how the food and drinks industry (FDI) is one of the key drivers of the global epidemic of childhood overweight and obesity. [PDF]

open access: yesBMJ Paediatr Open
Spencer N   +10 more
europepmc   +1 more source

<i>Momordica charantia</i> L. (Cucurbitaceae) Leaf Extract from Phytochemical Characterization and Toxicity Evaluation to Modulation of Pro-Inflammatory Cytokines and MAPK/NFκB Pathways. [PDF]

open access: yesMolecules
Oliveira MLA   +13 more
europepmc   +1 more source

A cul-de-sac effect makes Emilia-Romagna more prone to floods in a changing climate. [PDF]

open access: yesSci Rep
Scoccimarro E   +6 more
europepmc   +1 more source

A phase 3 study of ravulizumab to protect patients with chronic kidney disease from cardiac surgery-associated acute kidney injury and major adverse kidney events (ARTEMIS). [PDF]

open access: yesTrials
Ostermann M   +13 more
europepmc   +1 more source

Regulatory T cell therapy for xenotransplantation, what perspectives? [PDF]

open access: yesFront Immunol
Porret R   +10 more
europepmc   +1 more source

Bimatoprost Intracameral Implant (Durysta®): A New Era in Glaucoma Management Through Sustained-Release Innovation. [PDF]

open access: yesDrug Des Devel Ther
Vagiakis I   +5 more
europepmc   +1 more source

Integrative focus on the space exposome-integrome: physiological challenges and practical limits of countermeasures beyond low Earth orbit. [PDF]

open access: yesNPJ Microgravity
Bailey DM   +19 more
europepmc   +1 more source

Revealing an unexpectedly low electron injection threshold via reinforced shock acceleration. [PDF]

open access: yesNat Commun
Raptis S   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy